Julio Delgado

22PUBLICATIONS
133CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Jul 10, 2026
Clinical outcomes, patterns of relapse, and molecular landscape of advanced stage high-grade B-cell lymphoma.

|Aug 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.

Xavier Deschênes-Simard, Maria Bromberg, Sean M Devlin

|Dec 12, 2024
Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma.

Danny Luan, Susan DeWolf, Teng Fei

|Oct 29, 2024
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes.

Yannis K Valtis, Sean Devlin, Roni Shouval

|Oct 09, 2024
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.

Alfredo Rivas-Delgado, Cristina López, Guillem Clot

Pageof 4

Frequent Collaborators

11 joint publications

Elías Campo

10 joint publications

Ferran Nadeu

8 joint publications

Pablo Mozas

8 joint publications

Sílvia Beà